NASDAQ:IDYA
IDEAYA Biosciences Inc. Stock News
$37.71
-0.740 (-1.92%)
At Close: May 24, 2024
IDEAYA Announces Presentations at AACR Annual Meeting 2021 for Synthetic Lethality Programs IDE397 and PARG, and Kinase Inhibitor IDE196
06:00am, Thursday, 11'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 11, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and d
IDEAYA Biosciences Announces Inaugural Synthetic Lethality Investor Day
06:00am, Monday, 22'nd Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 /PRNewswire/ --IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and deve
SOUTH SAN FRANCISCO, Calif., Feb. 8, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and deve
IDEAYA to Participate in Upcoming February 2021 Investor Relations Events
06:00am, Monday, 01'st Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 1, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted
IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U.S. FDA
06:00am, Monday, 11'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted
IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
06:00am, Tuesday, 05'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 5, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted
IDEAYA Biosciences Announces Addition to NASDAQ Biotechnology Index
06:00am, Monday, 14'th Dec 2020
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targete
IDEAYA to Participate in Upcoming November 2020 Investor Relations Events
06:00am, Monday, 02'nd Nov 2020
SOUTH SAN FRANCISCO, Calif., Nov. 2, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
08:21am, Saturday, 05'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
What Kind Of Shareholders Hold The Majority In IDEAYA Biosciences, Inc.'s (NASDAQ:IDYA) Shares?
05:33pm, Wednesday, 19'th Aug 2020
Every investor in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) should be aware of the most powerful shareholder groups...
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
11:30am, Wednesday, 12'th Aug 2020
IDEAYA Biosciences, Inc. (IDYA) delivered earnings and revenue surprises of -126.34% and -100.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the s
IDEAYA Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update
10:00am, Wednesday, 12'th Aug 2020
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, provided a business update and announced fi
Is a Surprise Coming for IDEAYA Biosciences (IDYA) This Earnings Season?
12:33pm, Friday, 07'th Aug 2020
IDEAYA Biosciences (IDYA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
LD Micro--Announces Preliminary List of Presenters for the LD-500.
08:21pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Luminex Corp (DE) (LMNX) Q2 2020 Earnings Call Transcript | The Motley Fool
06:01am, Wednesday, 05'th Aug 2020
LMNX earnings call for the period ending June 30, 2020.
